Daniel Baltrukonis

617 total citations
14 papers, 267 citations indexed

About

Daniel Baltrukonis is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Baltrukonis has authored 14 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Baltrukonis's work include Biosimilars and Bioanalytical Methods (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Daniel Baltrukonis is often cited by papers focused on Biosimilars and Bioanalytical Methods (9 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Advanced Biosensing Techniques and Applications (3 papers). Daniel Baltrukonis collaborates with scholars based in United States, Denmark and Singapore. Daniel Baltrukonis's co-authors include Roberto A. Calle, Krischan J Hudson, Veena Somayaji, Jennifer Dong, Yali Liang, Martha Hernandez‐Illas, Michelle I. Rossulek, Deborah Finco, Boris Gorovits and Mary Birchler and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Clinical & Experimental Immunology.

In The Last Decade

Daniel Baltrukonis

13 papers receiving 260 citations

Peers

Daniel Baltrukonis

IMMUN

RNMI

EDM

ONCOL

Rocío Lledó‐García United Kingdom

Anthony Butterfield United States

Ana Campar Portugal

Barbara Siegele Germany

Debora M.I. Fersching Germany

Guiying Sun China

Keith Le United States

Ronald P. Schuyler United States

Jaafar N. Haidar United States

Shangwen Dong China

Rocío Lledó‐García United Kingdom

Daniel Baltrukonis

52 ×0.4

83 ×0.7

IMMUN

85 ×1.2

RNMI

37 ×1.2

EDM

25 ×1.0

ONCOL

Citations per year, relative to Daniel Baltrukonis Daniel Baltrukonis (= 1×) peers Rocío Lledó‐García

Countries citing papers authored by Daniel Baltrukonis

Since Specialization

Citations

This map shows the geographic impact of Daniel Baltrukonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Baltrukonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Baltrukonis more than expected).

Fields of papers citing papers by Daniel Baltrukonis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Baltrukonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Baltrukonis. The network helps show where Daniel Baltrukonis may publish in the future.

Co-authorship network of co-authors of Daniel Baltrukonis

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Baltrukonis. A scholar is included among the top collaborators of Daniel Baltrukonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Baltrukonis. Daniel Baltrukonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Grimaldi, Christine, Susan Richards, Daniel Baltrukonis, et al.. (2025). IQ Survey Results on Current Industry Practices—Part 1: Immunogenicity Risk Assessment. Clinical Pharmacology & Therapeutics. 117(6). 1596–1604.

Baltrukonis, Daniel, et al.. (2024). A Data Driven Strategy and Case Study for Implementation of Singlicate Analysis in Ligand Binding Assays Used for PK Quantitation. The AAPS Journal. 26(5). 88–88. 1 indexed citations

Yunis, Carla, et al.. (2023). Anti-drug Antibody Magnitude and Clinical Relevance Using Signal to Noise (S/N): Bococizumab Case Study. The AAPS Journal. 25(5). 85–85. 15 indexed citations

Tan, Charles Y., et al.. (2020). Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target Population. The AAPS Journal. 22(2). 19–19. 4 indexed citations

Gorovits, Boris, et al.. (2019). Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data Analysis. The AAPS Journal. 21(5). 76–76. 2 indexed citations

Wang, Ellen Q., Jack F. Bukowski, Carla Yunis, et al.. (2019). Assessing the Potential Risk of Cross-Reactivity Between Anti-Bococizumab Antibodies and Other Anti-PCSK9 Monoclonal Antibodies. BioDrugs. 33(5). 571–579. 7 indexed citations

Aleo, Michael D., et al.. (2019). Lens cholesterol biosynthesis inhibition: A common mechanism of cataract formation in laboratory animals by pharmaceutical products. Journal of Applied Toxicology. 39(9). 1348–1361. 4 indexed citations

Wang, Ellen Q., et al.. (2018). Comparative Pharmacokinetics and Pharmacodynamics of Bococizumab Following a Single Subcutaneous Injection Using Drug Substance Manufactured at Two Sites or Administration via Two Different Devices. Clinical Pharmacology in Drug Development. 8(1). 40–48. 4 indexed citations

Gorovits, Boris, Daniel Baltrukonis, Indranil Bhattacharya, et al.. (2018). Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab. Clinical & Experimental Immunology. 192(3). 348–365. 61 indexed citations

10.

Dong, Jennifer, Michelle I. Rossulek, Veena Somayaji, et al.. (2015). Pharmacokinetics and pharmacodynamics of PF‐05231023, a novel long‐acting FGF21 mimetic, in a first‐in‐human study. British Journal of Clinical Pharmacology. 80(5). 1051–1063. 85 indexed citations

11.

Dudal, Sherri, Daniel Baltrukonis, Alison Joyce, et al.. (2013). Assay Formats: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team. The AAPS Journal. 16(2). 194–205. 30 indexed citations

12.

Gustavson, Stephanie M., Veena Somayaji, Krischan J Hudson, et al.. (2011). Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 13(11). 1056–1058. 19 indexed citations

13.

Finco, Deborah, Daniel Baltrukonis, Adrienne Clements‐Egan, et al.. (2010). Comparison of competitive ligand-binding assay and bioassay formats for the measurement of neutralizing antibodies to protein therapeutics. Journal of Pharmaceutical and Biomedical Analysis. 54(2). 351–358. 29 indexed citations

14.

Baltrukonis, Daniel, Deborah Finco‐Kent, Thomas T. Kawabata, Martin Poirier, & Lynne LeSauteur. (2006). Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893. Journal of Immunotoxicology. 3(3). 157–164. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact